Targeted & controlled bone healing
24 Jul 19
Kuros announces Gerhard Ries is stepping down as Board member

Kuros announces Gerhard Ries is stepping down as Board member

Schlieren (Zurich), Switzerland, July 24, 2019 – Kuros Biosciences today announced that Gerhard Ries is stepping down as a member of the Board of Directors for personal reasons.

 

In future, the Board of Directors will consist of six members. Leanna Caron replaces Ries as Chair of the Compensation Committee and Jason Hannon as a member of the Compensation Committee until the next ordinary shareholders' meeting. Scott Bruder will replace Ries as a member of the Audit Committee.

 

Clemens van Blitterswijk, Chairman of Kuros, said: “We are very grateful for Gerhard’s service to Kuros as member of the Board, where he has brought us the benefit of his extensive experience of the global pharmaceutical industry as both entrepreneur and investor over the last three years. We wish him all the best for the future.”



Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Analysts
  5. Calendar
  6. Corporate governance
  7. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Article
24 Jul 19
Kuros announces Gerhard Ries is stepping down as Board member

Kuros announces Gerhard Ries is stepping down as Board member

Schlieren (Zurich), Switzerland, July 24, 2019 – Kuros Biosciences today announced that Gerhard Ries is stepping down as a member of the Board of Directors for personal reasons.

 

In future, the Board of Directors will consist of six members. Leanna Caron replaces Ries as Chair of the Compensation Committee and Jason Hannon as a member of the Compensation Committee until the next ordinary shareholders' meeting. Scott Bruder will replace Ries as a member of the Audit Committee.

 

Clemens van Blitterswijk, Chairman of Kuros, said: “We are very grateful for Gerhard’s service to Kuros as member of the Board, where he has brought us the benefit of his extensive experience of the global pharmaceutical industry as both entrepreneur and investor over the last three years. We wish him all the best for the future.”